Dilution of Share Value from the Exercise of Stock Acquisition Rights
First written in FY2017. 23 of 30 entries say "Materialised", first in FY2018-Q2. Latest entry: FY2027-H1.
No.1 moved to the "Worse" side of this theme in 2017, 4 years before the typical company in this theme (2021).
The whole theme swung hardest in 2017: 28 of 54 companies on the "Worse" side.
56 other companies' latest entry also says "Materialised".
- FY2027-H1MaterialisedAnnual report
「During the interim consolidated accounting period, the disposal of treasury shares in connection with the exercise of the 10th Series Stock Acquisition Rights resulted in a ¥315.590 million decrease in treasury shares, a ¥93.136 million decrease in capital surplus and a ¥50.117 million decrease in retained earnings.」
The disposal of treasury shares in connection with the exercise of the 10th Series Stock Acquisition Rights was carried out, resulting in an actual change related to dilution through a decrease in treasury shares and other items. - FY2026-H1MaterialisedAnnual report
「1 March 2025–31 August 2025 1 March 2025–31 August 2025 (Note) This represents an increase resulting from the exercise of stock acquisition rights.」
During the interim consolidated accounting period, the number of shares increased by 3,120 through the exercise of stock acquisition rights, with potential dilution continuing to materialise through the actual issuance of shares. - FY2025WorsenedAnnual report
「10th Series Stock Acquisition Rights Common shares － 180,800 － 180,800 2,384 11th Series Stock Acquisition Rights Common shares － 200,000 － 200,000 128」
180,800 shares underlying the 10th Series Stock Acquisition Rights and 200,000 shares underlying the 11th Series Stock Acquisition Rights were newly granted, increasing the potential dilution exposure. - FY2025-H1WorsenedAnnual report
「Overview of potential shares that were not included in the calculation of diluted interim net income per share because they had no dilutive effect, but had undergone significant changes from the end of the previous consolidated fiscal year － 1 class of stock acquisition rights (2,000 11th Series Stock Acquisition Rights, 200,000 shares).」
The 2,000 11th Series Stock Acquisition Rights, representing 200,000 underlying shares, are disclosed as potential shares that underwent significant changes from the end of the previous consolidated fiscal year. They were not included in the calculation of earnings per share because they had no dilutive effect, but the additional potential dilution exposure was explicitly disclosed. - FY2025-Q1MaterialisedAnnual report
「1 March 2024–31 May 2024 (Note) 1 480 6,954,920 156 630,139 156 551,252 10 May 2024 (Note) 2 31,900 6,986,820 14,993 645,132 14,993 566,245 (Note) 1. Increase due to the exercise of stock acquisition rights. 2. Paid third-party allotment Issue price ¥940 Capitalisation amount ¥470 Allottee グロースパートナーズ投資組合」
In addition to the 480 shares added through the exercise of stock acquisition rights, a paid third-party allotment of 31,900 shares was conducted with グロースパートナーズ投資組合 as the allottee. - FY2024MaterialisedAnnual report
「1 March 2023–29 February 2024 (Note) 1 82,920 6,954,440 6,150 629,982 6,150 551,095 (Note) 1. Increase due to the exercise of stock acquisition rights.」
During the fiscal year, 82,920 shares were added through the exercise of stock acquisition rights, and dilution has continued to materialise as actual share issuance. - FY2024-Q2MaterialisedAnnual report
「1 June 2023–31 August 2023 14,160 6,954,440 2,280 629,982 2,280 551,096 (Note) Increase due to the exercise of stock acquisition rights.」
During the second-quarter accounting period, 14,160 shares were added through the exercise of stock acquisition rights, and dilution has continued to materialise as actual share issuance. - FY2024-Q1MaterialisedAnnual report
「1 March 2023–31 May 2023 (Note) 68,760 6,940,280 3,870 627,702 3,870 548,815 (Note) Increase due to the exercise of stock acquisition rights.」
During the first-quarter accounting period, 68,760 shares were added through the exercise of stock acquisition rights, and dilution has continued to materialise as actual share issuance. - FY2023-Q3MaterialisedAnnual report
「1 September 2022–30 November 2022 (Note) 23,880 6,771,200 1,519 610,445 1,519 531,558 (Note) 1. Increase due to the exercise of stock acquisition rights. 2. Between 1 December 2022 and 31 December 2022, the number of issued shares increased by 49,320 through the exercise of stock acquisition rights, while capital and capital surplus each increased by ¥6,673 thousand.」
During the third-quarter accounting period, 23,880 shares were added through the exercise of stock acquisition rights, and an increase of 49,320 shares in December before the submission date was also disclosed. Dilution has continued to materialise as actual share issuance. - FY2023-Q2MaterialisedAnnual report
「1 June 2022–31 August 2022 5,160 6,747,320 288 608,926 288 530,039 (Note) 1. Increase due to the issuance of new shares through the exercise of stock acquisition rights.」
During the second-quarter accounting period, 5,160 shares were added through the exercise of stock acquisition rights, and the dilution risk has continued to materialise as actual share issuance. - FY2023-Q1MaterialisedAnnual report
「1 March 2022–31 May 2022 1,440 6,742,160 372 608,637 372 529,750 (Note) Increase due to the exercise of stock acquisition rights.」
During the first-quarter accounting period, 1,440 shares were added through the exercise of stock acquisition rights, and the dilution exposure has materialised as actual share issuance. - FY2022MaterialisedAnnual report
「Increase due to the exercise of stock acquisition rights 20,160 shares」
During the consolidated fiscal year, 20,160 shares were added through the exercise of stock acquisition rights, and dilution has continued to materialise as actual share issuance. - FY2022-Q3MaterialisedAnnual report
「1 September 2021–30 November 2021 (Note) 16,800 6,740,600 2,211 608,247 2,211 529,360 (Note) Increase due to the exercise of stock acquisition rights.」
During the third-quarter accounting period, 16,800 shares were added through the exercise of stock acquisition rights, and the dilution exposure has materialised as actual share issuance. - FY2022-Q2MaterialisedAnnual report
「1 June 2021–31 August 2021 16,600 6,723,800 10,433 606,036 10,433 527,149 (Note) 1. Increase due to the exercise of stock acquisition rights and the issuance of new shares as restricted stock compensation.」
During the second-quarter accounting period, 16,600 shares were added through the exercise of stock acquisition rights and other transactions. In addition, 13,920 shares were added through the exercise of stock acquisition rights in September, and the dilution exposure has continued to materialise as actual share issuance. - FY2022-Q1MaterialisedAnnual report
「The increase resulted from the exercise of stock acquisition rights.」
During the first quarter-to-date period, 2,640 shares were added through the exercise of stock acquisition rights, and the dilution exposure has materialised as actual share issuance. - FY2021MaterialisedAnnual report
「Increase due to the exercise of stock acquisition rights 411,240 shares」
During the consolidated fiscal year, 411,240 shares were added through the exercise of stock acquisition rights, and the dilution exposure has materialised as actual share issuance. - FY2021-Q3MaterialisedAnnual report
「2. 238,920 shares have been added through the exercise of stock acquisition rights.」
During the third-quarter accounting period, 238,920 shares were added through the exercise of stock acquisition rights, and the dilution exposure has materialised as actual share issuance. - FY2021-Q2MaterialisedAnnual report
「1 June 2020–31 August 2020 (Note) 1 240 3,146,900 108 521,589 108 465,614 (Note) 1. Increase due to the exercise of stock acquisition rights.」
During the second-quarter accounting period, 240 shares were added through the exercise of stock acquisition rights, and the dilution exposure has materialised as actual share issuance. - FY2020SoftenedAnnual report
「As of the end of the month preceding the submission date of this document, the total number of potential shares from stock acquisition rights was 488,340 shares, equivalent to 13.4% of the total issued shares including potential shares, which was 3,635,000 shares.」
The potential share ratio declined from 14.1% in the previous fiscal year to 13.4%. - FY2020-Q3MaterialisedAnnual report
「1 September 2019–30 November 2019 (Note) 2,460 3,144,800 274 520,980 274 465,004 (Note) Increase due to the exercise of stock acquisition rights.」
During the third-quarter accounting period, 2,460 shares were added through the exercise of stock acquisition rights, and the dilution exposure has continued to materialise as actual share issuance. - FY2020-Q2MaterialisedAnnual report
「1 June 2019–31 August 2019 (Note) 9,120 3,142,340 1,507 520,705 1,507 464,730 (Note) Increase due to the exercise of stock acquisition rights.」
During the second-quarter accounting period, 9,120 shares were added through the exercise of stock acquisition rights, and the dilution exposure has materialised as actual share issuance. - FY2020-Q1MaterialisedAnnual report
「1 March 2019–31 May 2019 4,860 3,133,220 541 519,198 541 463,222 (Note) Increase due to the exercise of stock acquisition rights.」
During the first quarter, 4,860 shares were added through the exercise of stock acquisition rights, and the dilution exposure has materialised as actual share issuance. - FY2019SoftenedAnnual report
「As of the end of the month preceding the submission date of this document, the total number of potential shares from stock acquisition rights was 514,680 shares, equivalent to 14.1% of the total issued shares including potential shares, which was 3,643,040 shares.」
The potential share ratio declined slightly from 14.2% stated for the previous fiscal year to 14.1%. - FY2019-Q3MaterialisedAnnual report
「1 September 2018–30 November 2018 (Note 2) 60 3,127,580 16 518,569 16 462,594 2. Increase due to the exercise of stock acquisition rights.」
During the third-quarter accounting period, 60 shares were added through the exercise of stock acquisition rights, and the dilution exposure has continued to materialise as actual share issuance. - FY2019-Q2MaterialisedAnnual report
「240 1,563,760 63 518,552 63 462,577 1 June 2018–31 August 2018 (Note) 1. Increase due to the exercise of stock acquisition rights.」
During the second quarter, the total number of issued shares increased by 240 through the exercise of stock acquisition rights, and the dilution exposure has continued to materialise as actual share issuance. - FY2019-Q1MaterialisedAnnual report
「Change in total issued shares: 630 shares. / (Note) 1. Increase due to the exercise of stock acquisition rights.」
During the first quarter, 630 shares were issued through the exercise of stock acquisition rights, and the dilution exposure has continued to materialise as actual share issuance. - FY2018WorsenedAnnual report
「As of the end of the month preceding the submission date of this document, the total number of potential shares from stock acquisition rights was 259,020 shares, equivalent to 14.2% of the total issued shares including potential shares, which was 1,822,510 shares.」
The potential share ratio increased from 11.5% stated for FY2017 to 14.2%. This includes 75,960 shares underlying the 8th Series Stock Acquisition Rights, among others. - FY2018-Q3WorsenedAnnual report
「Number of shares underlying stock acquisition rights (shares) 75,960 (Note) 1」
The 8th Series Stock Acquisition Rights were issued, adding 75,960 potential underlying shares and increasing the existing dilution exposure from stock acquisition rights. - FY2018-Q2MaterialisedAnnual report
「Change in total issued shares: 6,180 shares. Increase due to the exercise of stock acquisition rights.」
6,180 shares were added through the exercise of stock acquisition rights, and the risk of share value dilution has materialised as an actual share issuance. The section on stock acquisition rights and other matters states that there are no applicable items. - FY2017First statedAnnual report
「As of the end of the month preceding the submission date of this document, the total number of potential shares from stock acquisition rights was 200,370 shares, equivalent to 11.5% of the total issued shares including potential shares, which was 1,739,290 shares.」
States that exercise of stock acquisition rights may dilute the value of each share.